Large-scale testing (Phase 3)Study completedNCT02751931
What this trial is testing
Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity
Who this might be right for
Neurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 91